Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,990 | 17,230 | 22,360 | -3,850 | -11,400 |
| Depreciation Amortization | 500 | 390 | 240 | 110 | 260 |
| Other Working Capital | 3,100 | 510 | -410 | -1,070 | -510 |
| Other Operating Activity | -30,130 | -30,250 | -30,260 | 0 | 10 |
| Operating Cash Flow | $-15,540 | $-12,120 | $-8,070 | $-4,810 | $-11,640 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -30 | -20 | -940 |
| Other Investing Activity | 30,380 | 30,380 | 30,260 | 0 | -250 |
| Investing Cash Flow | $30,350 | $30,350 | $30,230 | $-20 | $-1,190 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1 | -1 | -1 | -4 | -1 |
| Other Financing Activity | 1,551 | 1,521 | 631 | 174 | 751 |
| Financing Cash Flow | $1,550 | $1,520 | $630 | $170 | $750 |
| Beginning Cash Position | 6,920 | 6,920 | 6,920 | 6,920 | 19,010 |
| End Cash Position | 23,280 | 26,680 | 29,720 | 2,250 | 6,920 |
| Net Cash Flow | $16,360 | $19,750 | $22,790 | $-4,670 | $-12,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,540 | -12,120 | -8,070 | -4,810 | -11,640 |
| Free Cash Flow | -15,540 | -12,120 | -8,070 | -4,810 | -11,640 |